LD-2 disclosure · 4th Quarter - Report
BIOWOUND SOLUTIONS
Client
- Description
- Biologics Company
- Location
- Nevada · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedicare/Medicaid
Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). H.R.6852 - To amend title XVIII of the Social Security Act to adjust payment for skin substitute products under the Medicare program. Issues related to skin substitute payment in 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F)
LobbyistsJOHN MCMANUS · ALEX WHALEN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)